media – Page 468 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Next Generation Drug Could Treat Inherited Form of ALS in Animal Models

New research funded by the NIH found that a second-generation drug, when injected in rodents, deferred signs of amyotrophic lateral sclerosis (ALS).
- Source: ScienceDaily
- 546
- August 2, 2018
ALS Clinical Trial Researches
Clinical Innovations enters China with new Shanghai Subsidiary

Clinical Innovations has launched its new subsidiary in Shanghai to grow in the Chinese labor and delivery market, expanding its global footprint.
- Source: FierceBiotech
- 1,110
- August 2, 2018
China Company Insight medical device
HiFiBiO Receives New Funding, Inks R&D Deal with Takeda

HiFiBiO Therapeutics is aspiring to work on antibody therapies for different gastrointestinal diseases, cancers and other disorders by signing a pact with Japanese Pharma and biotech company Takeda.
- Source: FierceBiotech
- 759
- August 2, 2018
biotech Company Insight Takeda
$7.6M Granted to SkinVision to Expand Skin Cancer App

$7.6 million has been granted to SkinVision, an Amsterdam-based skin cancer screening app, as backing from active investors Leo Pharma and PHS Fund, with supplementary aid from unnamed new sponsors which the company called "high net worth impact investors."
- Source: MobiHealthNews
- 779
- August 2, 2018
Market Views mHealth skin cancer
Connected Health Platform Hopes to Enhance Manner in Which Patients Take Medication

Phillips-Medisize introduced a connected health platform to enhance the way people take medication while using connected health devices.
- Source: DigitalHealthAge
- 742
- August 2, 2018
Company Insight digital health medical device Phillips
Experimental Drug to Treat Alzheimer Disease

The condition of memory loss is termed as Alzheimer’s disease, affecting more than 5 million people and there is still no definite cure. A research team reported that an experimental drug could treat Alzheimer’s disease by slowing down the process of clear thinking and memory.
- Source: NBCNews
- 692
- August 1, 2018
Alzheimer's disease Researches
Intermittent Fasting Could Reduce Multiple Sclerosis Symptoms

A research team from Washington University in St. Louis has been trying to investigate whether intermittent fasting could reduce multiple sclerosis symptoms, especially inflammation.
- Source: HealthLine
- 646
- August 1, 2018
multiple sclerosis Researches
Nebraska Informs Pfizer to Prosecute Over Lethal Injection

Pfizer objected to the use of its drugs for lethal injection procedures last year by asking states to return the drugs immediately for a refund. But not all of them have halted its utilization. Hence, with an execution planned in Nebraska dated Aug. 14, a state senator is urging Pfizer to prosecute if the drug usage is not halted.
- Source: FiercePharma
- 958
- August 1, 2018
Company Insight Pfizer pharmaceutical
Adherium Receives FDA Clearance for Hailie Inhaler Sensor

Adherium, the makers of inhaler sensors, has received 510(k) US-FDA clearance for the sales of its Hailie sensor, previously known as Smartinhaler. The individual versions of this device were previously cleared for use with the asthma inhalers like Ventolin HFA, ProAir HFA, and Flovent HFA.
- Source: MobiHealthNews
- 1,262
- August 1, 2018
asthma FDA New Approvals
FDA Warns of Unapproved Vaginal ‘Rejuvenation’ Procedures

The US-FDA has warned against medical device manufacturers for developing cosmetic vaginal rejuvenation procedures to treat vaginal atrophy, laxity, itching/dryness, pain during sex or urination and reduced sexual sensation.
- Source: Medpagetoday
- 858
- August 1, 2018
FDA Policies

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.